The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [18F] fluorodeoxyglucose positron emission tomography scan

Paul B. Romesser, Remy Lim, Daniel E. Spratt, Jeremy Setton, Nadeem Riaz, Benjamin Lok, Shyam Rao, Eric J. Sherman, Heiko Schöder, Nancy Y. Lee

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objectives This study compared the relative prognostic utility of the Gross Tumor Volume (GTV), maximum Standardized Uptake Value (SUVmax), and Metabolic Tumor Volume (MTV) in a uniform cohort of oropharyngeal squamous cell carcinoma (OPSCC) patients treated with platinum-based concurrent chemoradiation therapy (CCRT). Methods and materials One-hundred OPSCC with a pretreatment [18F] fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) were treated with CCRT. Kaplan-Meier curves and Cox proportional hazard models were generated. Results When dichotomized by the median, a smaller MTV correlated with improved 5 year locoregional control (LRC) (98.0% versus 87.0%, p = 0.049), freedom from distant metastasis (FDM) (91.7% versus 65.0%, p = 0.005), progression-free survival (PFS) (80.3% versus 56.7%, p = 0.015), and overall survival (OS) (84.1% versus 57.8%, p = 0.008), whereas a smaller GTV correlated with improved PFS (80.3% versus 57.4%, p = 0.040) and OS (82.1% versus 60.1%, p = 0.025). SUVmax failed to correlate with any outcome. On multivariate analysis, when adjusted for GTV, T-stage, and N-stage a smaller MTV remained independently correlated with improved FDM, PFS, and OS. GTV failed to reach significance in the multivariate model. Conclusions A smaller MTV correlates with improved LRC, FDM, PFS, and OS in OPSCC patients undergoing platinum-based CCRT.

Original languageEnglish (US)
Pages (from-to)802-808
Number of pages7
JournalOral Oncology
Volume50
Issue number9
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Oropharyngeal Neoplasms
Fluorodeoxyglucose F18
Platinum
Tumor Burden
Positron-Emission Tomography
Disease-Free Survival
Squamous Cell Carcinoma
Survival
Therapeutics
Neoplasm Metastasis
Proportional Hazards Models
Multivariate Analysis

Keywords

  • Gross Tumor Volume (GTV)
  • Head and neck cancer
  • Metabolic Tumor Volume (MTV)
  • Oropharyngeal cancer
  • PET
  • Standardized Uptake Value (SUV)

ASJC Scopus subject areas

  • Oncology
  • Oral Surgery
  • Cancer Research
  • Medicine(all)

Cite this

The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [18F] fluorodeoxyglucose positron emission tomography scan. / Romesser, Paul B.; Lim, Remy; Spratt, Daniel E.; Setton, Jeremy; Riaz, Nadeem; Lok, Benjamin; Rao, Shyam; Sherman, Eric J.; Schöder, Heiko; Lee, Nancy Y.

In: Oral Oncology, Vol. 50, No. 9, 01.01.2014, p. 802-808.

Research output: Contribution to journalArticle

@article{a2ea31c478e1486eb777ee384bd093f6,
title = "The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [18F] fluorodeoxyglucose positron emission tomography scan",
abstract = "Objectives This study compared the relative prognostic utility of the Gross Tumor Volume (GTV), maximum Standardized Uptake Value (SUVmax), and Metabolic Tumor Volume (MTV) in a uniform cohort of oropharyngeal squamous cell carcinoma (OPSCC) patients treated with platinum-based concurrent chemoradiation therapy (CCRT). Methods and materials One-hundred OPSCC with a pretreatment [18F] fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) were treated with CCRT. Kaplan-Meier curves and Cox proportional hazard models were generated. Results When dichotomized by the median, a smaller MTV correlated with improved 5 year locoregional control (LRC) (98.0{\%} versus 87.0{\%}, p = 0.049), freedom from distant metastasis (FDM) (91.7{\%} versus 65.0{\%}, p = 0.005), progression-free survival (PFS) (80.3{\%} versus 56.7{\%}, p = 0.015), and overall survival (OS) (84.1{\%} versus 57.8{\%}, p = 0.008), whereas a smaller GTV correlated with improved PFS (80.3{\%} versus 57.4{\%}, p = 0.040) and OS (82.1{\%} versus 60.1{\%}, p = 0.025). SUVmax failed to correlate with any outcome. On multivariate analysis, when adjusted for GTV, T-stage, and N-stage a smaller MTV remained independently correlated with improved FDM, PFS, and OS. GTV failed to reach significance in the multivariate model. Conclusions A smaller MTV correlates with improved LRC, FDM, PFS, and OS in OPSCC patients undergoing platinum-based CCRT.",
keywords = "Gross Tumor Volume (GTV), Head and neck cancer, Metabolic Tumor Volume (MTV), Oropharyngeal cancer, PET, Standardized Uptake Value (SUV)",
author = "Romesser, {Paul B.} and Remy Lim and Spratt, {Daniel E.} and Jeremy Setton and Nadeem Riaz and Benjamin Lok and Shyam Rao and Sherman, {Eric J.} and Heiko Sch{\"o}der and Lee, {Nancy Y.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.oraloncology.2014.06.018",
language = "English (US)",
volume = "50",
pages = "802--808",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [18F] fluorodeoxyglucose positron emission tomography scan

AU - Romesser, Paul B.

AU - Lim, Remy

AU - Spratt, Daniel E.

AU - Setton, Jeremy

AU - Riaz, Nadeem

AU - Lok, Benjamin

AU - Rao, Shyam

AU - Sherman, Eric J.

AU - Schöder, Heiko

AU - Lee, Nancy Y.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objectives This study compared the relative prognostic utility of the Gross Tumor Volume (GTV), maximum Standardized Uptake Value (SUVmax), and Metabolic Tumor Volume (MTV) in a uniform cohort of oropharyngeal squamous cell carcinoma (OPSCC) patients treated with platinum-based concurrent chemoradiation therapy (CCRT). Methods and materials One-hundred OPSCC with a pretreatment [18F] fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) were treated with CCRT. Kaplan-Meier curves and Cox proportional hazard models were generated. Results When dichotomized by the median, a smaller MTV correlated with improved 5 year locoregional control (LRC) (98.0% versus 87.0%, p = 0.049), freedom from distant metastasis (FDM) (91.7% versus 65.0%, p = 0.005), progression-free survival (PFS) (80.3% versus 56.7%, p = 0.015), and overall survival (OS) (84.1% versus 57.8%, p = 0.008), whereas a smaller GTV correlated with improved PFS (80.3% versus 57.4%, p = 0.040) and OS (82.1% versus 60.1%, p = 0.025). SUVmax failed to correlate with any outcome. On multivariate analysis, when adjusted for GTV, T-stage, and N-stage a smaller MTV remained independently correlated with improved FDM, PFS, and OS. GTV failed to reach significance in the multivariate model. Conclusions A smaller MTV correlates with improved LRC, FDM, PFS, and OS in OPSCC patients undergoing platinum-based CCRT.

AB - Objectives This study compared the relative prognostic utility of the Gross Tumor Volume (GTV), maximum Standardized Uptake Value (SUVmax), and Metabolic Tumor Volume (MTV) in a uniform cohort of oropharyngeal squamous cell carcinoma (OPSCC) patients treated with platinum-based concurrent chemoradiation therapy (CCRT). Methods and materials One-hundred OPSCC with a pretreatment [18F] fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) were treated with CCRT. Kaplan-Meier curves and Cox proportional hazard models were generated. Results When dichotomized by the median, a smaller MTV correlated with improved 5 year locoregional control (LRC) (98.0% versus 87.0%, p = 0.049), freedom from distant metastasis (FDM) (91.7% versus 65.0%, p = 0.005), progression-free survival (PFS) (80.3% versus 56.7%, p = 0.015), and overall survival (OS) (84.1% versus 57.8%, p = 0.008), whereas a smaller GTV correlated with improved PFS (80.3% versus 57.4%, p = 0.040) and OS (82.1% versus 60.1%, p = 0.025). SUVmax failed to correlate with any outcome. On multivariate analysis, when adjusted for GTV, T-stage, and N-stage a smaller MTV remained independently correlated with improved FDM, PFS, and OS. GTV failed to reach significance in the multivariate model. Conclusions A smaller MTV correlates with improved LRC, FDM, PFS, and OS in OPSCC patients undergoing platinum-based CCRT.

KW - Gross Tumor Volume (GTV)

KW - Head and neck cancer

KW - Metabolic Tumor Volume (MTV)

KW - Oropharyngeal cancer

KW - PET

KW - Standardized Uptake Value (SUV)

UR - http://www.scopus.com/inward/record.url?scp=84905919491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905919491&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2014.06.018

DO - 10.1016/j.oraloncology.2014.06.018

M3 - Article

C2 - 25043882

AN - SCOPUS:84905919491

VL - 50

SP - 802

EP - 808

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

IS - 9

ER -